Onderneming Concordia International Corp Nasdaq
Aandelen
CA20653P1027
Farmaceutische producten
Vakgebied
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Steffen Wagner
CEO | Chief Executive Officer | - | 01-04-22 |
Andreas Stickler
DFI | Director of Finance/CFO | 53 | 01-01-22 |
Nick Warwick
CTO | Chief Tech/Sci/R&D Officer | - | 01-06-20 |
Karl Belk
COO | Chief Operating Officer | 56 | 01-10-15 |
Adam Peeler
IRC | Investor Relations Contact | - | 01-11-15 |
Corporate Officer/Principal | - | - | |
General Counsel | - | 01-05-22 | |
Fiona Huzarski
HRO | Human Resources Officer | - | - |
Simon Tucker
PRN | Corporate Officer/Principal | - | 01-06-18 |
Chris Britten
PRN | Corporate Officer/Principal | - | - |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Raj Shah
BRD | Director/Board Member | 55 | - |
Rainer Lenhard
BRD | Director/Board Member | - | - |
Steffen Wagner
CEO | Chief Executive Officer | - | 01-04-22 |
Andreas Stickler
DFI | Director of Finance/CFO | 53 | 01-01-22 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 48 913 490 | 48 854 243 ( 99,88 %) | 0 | 99,88 % |
Bedrijfsgegevens
Advanz Pharma Corp. Ltd.
Capital House 85 King William Street
EC4N 7BL, London
+44 2085 889 100
http://www.advanzpharma.comBedrijven van de groep
Naam | Categorie en sector |
---|---|
Advanz Pharma (Jersey) Ltd.
Advanz Pharma (Jersey) Ltd. Pharmaceuticals: MajorHealth Technology Part of Advanz Pharma Corp. Ltd., Advanz Pharma (Jersey) Ltd. develops pharmaceutical products and medical devices. The company is based in St. Helier, UK. |
Pharmaceuticals: Major
|
Sector
Vaira. 1 jan. | Kapi. | |
---|---|---|
+41,96% | 630 mld. | |
-7,15% | 350 mld. | |
+18,77% | 328 mld. | |
+8,79% | 298 mld. | |
+18,02% | 246 mld. | |
+1,27% | 225 mld. | |
+11,95% | 218 mld. | |
+3,68% | 160 mld. | |
-4,38% | 156 mld. |